Sebastian Dziadek

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Dinesh Khanna, Christopher P. Denton, Angelika Jahreis et al. · The Lancet · 2016 · 669 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +5

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

Gennaro Pagano, Kirsten I. Taylor, Judith Anzures‐Cabrera et al. · New England Journal of Medicine · 2022 · 395 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis

Hong Xin, Sebastian Dziadek, David R. Bundle et al. · Proceedings of the National Academy of Sciences · 2008 · 219 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson’s disease brain as revealed by multicolor STED microscopy

Tim E. Moors, Christina A. Maat, Daniel Niedieker et al. · Acta Neuropathologica · 2021 · 155 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

A Fully Synthetic Vaccine Consisting of a Tumor‐Associated Glycopeptide Antigen and a T‐Cell Epitope for the Induction of a Highly Specific Humoral Immune Response

Sebastian Dziadek, Alexandra Hobel, Edgar Schmitt et al. · Angewandte Chemie International Edition · 2005 · 139 citations

Life Sciences, Immunology, Oncology +17